CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −13,998 | 1,536,024 | ||
| 2023-12-27 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +76,031 | $3.95 | $301K | 164,470 |
| 2023-12-27 | Schlanger David J Executive Chairman | Sale 10b5-1 | −76,031 | $37.66 | $2.9M | 88,439 |
| 2023-12-27 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −76,031 | 1,550,022 | ||
| 2023-12-26 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +80,000 | $3.95 | $316K | 168,439 |
| 2023-12-26 | Schlanger David J Executive Chairman | Sale 10b5-1 | −80,000 | $37.93 | $3.0M | 88,439 |
| 2023-12-26 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −80,000 | 1,626,053 | ||
| 2023-12-22 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +80,000 | $3.95 | $316K | 168,439 |
| 2023-12-22 | Schlanger David J Executive Chairman | Sale 10b5-1 | −80,000 | $38.11 | $3.0M | 88,439 |
| 2023-12-22 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −80,000 | 1,706,053 | ||
| 2023-12-21 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +80,000 | $3.95 | $316K | 168,439 |
| 2023-12-21 | Schlanger David J Executive Chairman | Sale 10b5-1 | −80,000 | $37.65 | $3.0M | 88,439 |
| 2023-12-21 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −80,000 | 1,786,053 | ||
| 2023-12-20 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +2,906 | $3.95 | $11K | 91,345 |
| 2023-12-20 | Schlanger David J Executive Chairman | Sale 10b5-1 | −2,906 | $37.50 | $109K | 88,439 |
| 2023-12-20 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −2,906 | 1,866,053 | ||
| 2023-12-14 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +1,063 | $3.95 | $4K | 89,502 |
| 2023-12-14 | Schlanger David J Executive Chairman | Sale 10b5-1 | −1,063 | $37.53 | $40K | 88,439 |
| 2023-12-14 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −1,063 | 1,868,959 | ||
| 2023-12-11 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −112 | $36.26 | $4K | 49,871 |
Page 17 of 77 · 1,524 trades